A type of breast cancer.  The cells don’t usually have receptors for oestrogen, progesterone or the HER2/neu protein, so doctors may call it ‘triple negative breast cancer’. It is unlikely to respond to hormone therapy or Herceptin. Women diagnosed may be younger than with other types of breast cancer – sometimes in their 30s. It’s more common in African-American women than in other ethnic groups.